Kevin King

Kevin King is a senior executive at BioIVT with extensive experience in the biotherapeutics and cell therapy industries. Here are the key details about his professional background:

Current Role

Kevin King currently serves as the Senior Director of CGT (Cell and Gene Therapy) Strategy and Growth at BioIVT, a position he has held since January 2022.2 Prior to this, he was the Senior Director of Immune Cell Operations at the same company.4

Professional Experience

BioIVT Career:

• Joined BioIVT in October 20194
• Focused on growing BioIVT's donor center network and enhancing capabilities for Cell and Gene Therapies3
• Led efforts to improve immune cell operations and expand the company's presence in the cell therapy field

Previous Experience: Before joining BioIVT, Kevin King had a distinguished career in the biopharmaceutical industry:

• Senior Director at Pfizer, where he held multiple leadership roles:

  • Portfolio & Project Management in Biotherapeutics Pharmaceutical Sciences
  • Analytical R&D
  • Formulation & Process Development1

• Prior to Pfizer, he worked at:

  • Hoffmann-La Roche (Switzerland)
  • Procter & Gamble (UK)
  • Lonza Biologics (UK)1

Education and Expertise

• Biochemist by training
• Graduate of the University of Wales, UK
• Over 25 years of experience in biotherapeutics development1

Key Responsibilities

At Pfizer, Kevin's roles included:

• Overseeing the interface between Research and Development for biotherapeutic modalities
• Managing release and stability testing of clinical supplies for various biotherapeutic products
• Leading microbiological testing of biotherapeutic materials and facilities
• Partnering with Pfizer Global Supplies for method transfer and validation
• Maintaining regulatory compliance and interacting with inspectors and auditors
• Executing strategic outsourcing plans for analytical testing and characterization1

Kevin King's extensive experience in biotherapeutics and his current focus on cell and gene therapy strategy at BioIVT demonstrate his significant role in advancing innovative medical treatments and research capabilities in the biotechnology sector.